Andere Sprachen PEPTONIC medical AB

Aktien

PMED

SE0005962206

PMED

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 31.01.2024			% 5 Tage	% 1. Jan.
0,06 ^SEK	-.--%		-.--%	+3,45 %

31.05.	Peptonic Medical AB erteilt Patent in Europa zur Linderung von provozierter Vulvodynie bei Frauen, Produkt bereit zur Markteinführung	CI
21.05.	Peptonic Medical AB kündigt organisatorische Änderungen an	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Peptonic Medical: Peptonic announces outcome in the rights issue and the directed issue	14.06.
Peptonic announces outcome in the rights issue and the directed issue	14.06.
Peptonic Medical provides an operational update after the first 120 days with new CEO	11.06.
Last day of trading with the unit rights in Peptonic	07.06.
Peptonic Medical Secures European Patent for Treatment of Vulvodynia	31.05.
Peptonic Medical AB granted patent in Europe for relief of provoked vulvodynia in women. Product ready for launch.	31.05.
Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch	31.05.
The subscription period in Peptonic's rights issue of units starts today	28.05.
Peptonic publishes prospectus in connection with rights issue of units	24.05.
PEPTONIC medical : Interim report Jan-March 2024	23.05.
Peptonic Medical AB Announces Organizational Changes	21.05.
Peptonic Medical AB Announces Organizational Changes	21.05.
The board of Peptonic has decided to carry out a directed issue of units consisting of shares and warrants of series TO5	19.05.
PEPTONIC medical : Updated year end report Jan-Dec 2023	16.05.
PEPTONIC medical : Year end report Jan Dec 2023	16.05.
Sweden’s Peptonic Medical Names New CFO	15.05.
Jenni Björnulfson appointed as new CFO of Peptonic Medical	15.05.
PEPTONIC medical AB Announces Chief Financial Officer Changes	15.05.
Warrants of series TO4 were subscribed to approximately 1.80 percent and Peptonic receives approximately SEK 0.1 million	07.05.
PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PEPTONIC medical AB

Aktien

PMED

SE0005962206

PMED

Andere Sprachen

Filter